Akebia Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Akebia Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Akebia Therapeutics Inc.
Rating: 1.3636945
Author: Trendlyne DVM scores

Weak Stock

about

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a m...

1.06 -0.07 (-6.19%)

New 52W Low today

4.8M

XNAS Volume

XNAS 15 May, 2026 5:30 PM (EDT)

Low Financial Strength

27.8 / 100

Mid Valuation

32.5 / 100

Technically Bearish

21.0 / 100

Weak Stock These stocks have weak financials and momentum. Buying interest is low. While the stock is affordable, investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 296%

5 analysts

Akebia Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Akebia Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a m...

New 52W Low today

SWOT Analysis

Akebia Therapeutics Inc Live Price Chart